Does every patient with Staphylococcus aureus bacteremia require a transesophageal echocardiogram (TEE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Every Staph Aureus Bacteremia Need TEE?

No, not every patient with Staphylococcus aureus bacteremia requires TEE, but all patients should undergo at least transthoracic echocardiography (TTE), with TEE reserved for those with high-risk features or when clinical suspicion for endocarditis remains high despite negative TTE. 1

Initial Echocardiographic Approach

All patients with SAB should undergo TTE as the first-line imaging modality given the frequency of infective endocarditis (IE) in this setting (approximately 12-25% of cases), the virulence of S. aureus, and its devastating effects once intracardiac infection is established. 1, 2, 3

  • TTE has a sensitivity of only 63-70% for detecting vegetations in native valves and 50% in prosthetic valves 1, 3
  • TEE has superior sensitivity of 88-96% for native valves and 92% for prosthetic valves 1, 3

When TEE is Mandatory (Class I Recommendations)

TEE should be performed in the following situations:

  • Negative or non-diagnostic TTE when clinical suspicion for IE remains high 1
  • Prosthetic heart valve or intracardiac device present (e.g., permanent pacemaker, implantable defibrillator) 1, 3
  • Positive TTE with concern for intracardiac complications (abscess, perivalvular extension) 1
  • New complications during therapy (new murmur, embolism, persistent fever, heart failure, new AV block) 1

High-Risk Features Warranting TEE After Negative TTE

The European Society of Cardiology recommends TEE should be considered (Class IIa) based on individual patient risk factors and mode of acquisition. 1 Specific high-risk features include:

  • Persistent bacteremia ≥48 hours despite appropriate antibiotics 2, 3, 4
  • Persistent fever despite appropriate antibiotic therapy 3, 4
  • Implanted permanent pacemaker or other intracardiac prosthetics (32-fold increased risk of IE) 3
  • Metastatic infection foci 2, 4
  • Community-acquired SAB (higher risk than nosocomial) 4, 5
  • Hemodialysis dependence 5
  • Secondary foci of infection 5

Low-Risk Patients Who May Not Need TEE

TEE can be safely avoided in patients meeting ALL of the following low-risk criteria (negative predictive values 93-100%): 4, 6, 5

  • Absence of permanent intracardiac device
  • Sterile follow-up blood cultures within 4 days after initial positive set
  • No hemodialysis dependence
  • Nosocomial acquisition of SAB
  • Absence of secondary/metastatic foci of infection
  • No clinical signs of IE (no new murmur, no embolic phenomena)
  • PREDICT score ≤2 on day 5 (validated scoring system with 100% sensitivity and negative predictive value) 4

Timing Considerations

  • Initial TTE should be performed as soon as possible (within 12 hours of initial evaluation) 1
  • TEE should be performed as soon as possible when indicated, not delayed 1
  • Repeat TEE in 5-7 days (or sooner with S. aureus) if initial TEE is negative but clinical suspicion remains high 1

Special Consideration for Right-Sided IE

TEE is not mandatory in isolated right-sided native valve IE with good quality TTE examination and unequivocal echocardiographic findings. 1

Clinical Pitfalls to Avoid

  • Do not rely solely on TTE in high-risk patients - the sensitivity is inadequate (32-70%) and many cases of IE will be missed 3, 5
  • Do not assume nosocomial SAB is low-risk without evaluating other criteria - many patients have pre-existing indications for extended therapy independent of TEE findings 6
  • Do not delay TEE when indicated - early detection of complications impacts surgical timing and mortality 1, 2
  • Recognize that many patients with complicated SAB already have indications for extended antibiotic therapy (4-6 weeks) regardless of TEE findings, making TEE less likely to change management in these cases 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prospective Validation of PREDICT and Its Impact on the Transesophageal Echocardiography Use in Management of Staphylococcus aureus Bacteremia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Research

Forgoing transesophageal echocardiogram in selected patients with complicated Staphylococcus aureus bacteremia.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.